Perrigo has announced that it has begun shipping its generic version of Astepro azelastine nasal spray after the ANDA it submitted in partnership with Impax Laboratories received final approval from the FDA. In January 2012, after the two companies filed the ANDA, Astepro maker Meda Pharmaceuticals filed suit for patent infringement in US District Court. According to … [Read more...] about FDA approves Perrigo’s azelastine nasal spray
News
Anoro Ellipta approved in Europe
GlaxoSmithKline and Theravance have announced that they have received marketing authorization for the Anoro Ellipta umeclidinium/vilanterol DPI for the treatment of COPD in Europe. The EMA's Committee for Medicinal Products for Human Use (CHMP) issues a positive opinion regarding Anoro in February 2014. The approval triggers a $15 million milestone payment from … [Read more...] about Anoro Ellipta approved in Europe
MVIC adds four new member companies, opens registration for symposium
The Medicon Valley Inhalation Consortium (MVIC) has announced the addition of four new member companies, bringing the total to 24. The newly added companies are OM Projekt, Lastow Consulting, Competitive Intelligence Solutions (CIS), and AB Kamsaco. OM Projekt provides project management based on Lean Six Sigma; Lastow Consulting provides device development and … [Read more...] about MVIC adds four new member companies, opens registration for symposium
Aptar publishes summary of roundtable on inhaler adherence
Aptar Pharma has published a white paper summarizing a roundtable discussion on inhaler adherence held in Paris, France on November 29th 2013. The panel included five experts on inhaler usage from the UK and France. The company said, "Aptar Pharma and its distinguished scientific guests were delighted with the successful outcome of the inhaler adherence … [Read more...] about Aptar publishes summary of roundtable on inhaler adherence
Philips-Medisize to be acquired by Golden State Capital
Device manufacturer Phillips-Medisize has announced that it will be acquired by Golden Gate Capital for an undisclosed amount. According to the announcement, Matt Jennings will remain as President and CEO, and the company will keep its headquarters in Wisconsin. The company, which offers design and manufacturing services for medical devices, including inhalers, has … [Read more...] about Philips-Medisize to be acquired by Golden State Capital
New patents for Discovery Labs’ aerosol surfactant and delivery system
Discovery Laboratories has announced that the US Patent and Trademark Office (USPTO) has issued the company a new patent titled "Ventilation Circuit Adaptor and Proximal Aerosol Delivery System" (Patent No. 8,701,658) and Notices of Allowance for two patents titled "Lyophilization of Synthetic Liposomal Pulmonary Surfactant" (application nos.14/091,608 and … [Read more...] about New patents for Discovery Labs’ aerosol surfactant and delivery system
3M DDS to expand UK MDI facility
According to 3M Drug Delivery Systems, the company will increase the capacity of its Loughborough, UK MDI facility by more than 20%. No additional details were provided. 3M DDS VP of Inhalation Drug Delivery Marcello Napol said, “Since developing the first MDI almost 60 years ago, 3M has continued pioneering in inhalation drug delivery, and this expansion of our … [Read more...] about 3M DDS to expand UK MDI facility
Bayer acquires Afrin nasal spray
Merck has announced the sale of its Consumer Care division, which markets Afrin oxymetazoline nasal spray, to Bayer. According to Bayer, "The purchase price of USD 14.2 billion includes a payment associated with sales of Claritin and Afrin in certain countries where these products are still prescription-only." Bayer Chairman Marijn Dekkers cited Afrin as one of … [Read more...] about Bayer acquires Afrin nasal spray
FDA approves Propeller Health’s latest inhaler tracking system
Propeller Health (formerly known as Asthmapolis) has announced that the latest version of its inhaler tracking system has received 510(k) clearance from the FDA. The system includes a sensor that snaps onto an MDI and mobile apps that monitor and analyze inhaler use. According to Propeller, the newly approved system also predicts asthma and COPD exacerbations and … [Read more...] about FDA approves Propeller Health’s latest inhaler tracking system
Positive Phase 1b results for Pulmatrix LAMA DPI
Pulmatrix has announced that a recently completed Phase 1b study of its PUR0200 inhaled LAMA in COPD patients found that all three doses of PUR0200 produced significant improvement in lung function compared to placebo and comparable or greater to an active comparator. The company had announced initiation of the study in July 2013. PUR0200 is a carrier-free dry … [Read more...] about Positive Phase 1b results for Pulmatrix LAMA DPI